Preferred Stock Offerings
By Ru Back Packer Staff, updated Thursday, February 1, 6:56 AM
Slide #78. Rennova Health, Inc. — Preferred Stock Offering
||Rennova Health, Inc. (RNVA)
|Date of Pricing:
|Price Per Share:
|Preferred Stock Offering Details:
||Rennova Health, Inc. (NASDAQ: RNVA) today announced the pricing of an underwritten public offering of 12,350 shares of its Series H Convertible Preferred Stock at a per share price to the public of $1,000. The Series H Preferred Stock has a stated value of $1,000 per share with each share convertible into 11,111 shares of common stock, at a conversion price of $0.09 per share. The gross proceeds to Rennova Health, Inc. from this offering are expected to be approximately $12,350,000 before deducting underwriting discounts and commissions and other estimated offering expenses. Approximately $8,300,000 of the net proceeds from this offering will be used to redeem certain outstanding shares of Rennova Health's Series G Convertible Preferred Stock. The offering is expected to close on December 20, 2016, subject to customary closing conditions.
Rennova Health is a provider of a group of health care services for healthcare providers, their patients and individuals. Co. operates in three synergistic divisions with specialized management: Clinical diagnostics through its clinical laboratories, with emphasis on the provision of urine drug toxicology testing to physicians, clinics and rehabilitation facilities; supportive software solutions to healthcare providers including Electronic Health Records, Laboratory Information Systems and Medical Billing services; Decision support and interpretation of cancer and genomic diagnostics.
Open the RNVA Page at Ru Back Packer »
Open the RNVA Page at Ru Back Packer (in a new window) »